IBDEI03Y ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1316,1,3,0)
 ;;=3^Coagulation defect, unspecified
 ;;^UTILITY(U,$J,358.3,1316,1,4,0)
 ;;=4^D68.9
 ;;^UTILITY(U,$J,358.3,1316,2)
 ;;=^5002364
 ;;^UTILITY(U,$J,358.3,1317,0)
 ;;=D47.3^^3^39^31
 ;;^UTILITY(U,$J,358.3,1317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1317,1,3,0)
 ;;=3^Essential (hemorrhagic) thrombocythemia
 ;;^UTILITY(U,$J,358.3,1317,1,4,0)
 ;;=4^D47.3
 ;;^UTILITY(U,$J,358.3,1317,2)
 ;;=^5002258
 ;;^UTILITY(U,$J,358.3,1318,0)
 ;;=D69.6^^3^39^129
 ;;^UTILITY(U,$J,358.3,1318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1318,1,3,0)
 ;;=3^Thrombocytopenia, unspecified
 ;;^UTILITY(U,$J,358.3,1318,1,4,0)
 ;;=4^D69.6
 ;;^UTILITY(U,$J,358.3,1318,2)
 ;;=^5002370
 ;;^UTILITY(U,$J,358.3,1319,0)
 ;;=D75.1^^3^39^127
 ;;^UTILITY(U,$J,358.3,1319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1319,1,3,0)
 ;;=3^Secondary polycythemia
 ;;^UTILITY(U,$J,358.3,1319,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,1319,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,1320,0)
 ;;=M31.1^^3^39^130
 ;;^UTILITY(U,$J,358.3,1320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1320,1,3,0)
 ;;=3^Thrombotic microangiopathy
 ;;^UTILITY(U,$J,358.3,1320,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,1320,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,1321,0)
 ;;=I80.9^^3^39^92
 ;;^UTILITY(U,$J,358.3,1321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1321,1,3,0)
 ;;=3^Phlebitis and thrombophlebitis of unspecified site
 ;;^UTILITY(U,$J,358.3,1321,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,1321,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,1322,0)
 ;;=R59.9^^3^39^30
 ;;^UTILITY(U,$J,358.3,1322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1322,1,3,0)
 ;;=3^Enlarged lymph nodes, unspecified
 ;;^UTILITY(U,$J,358.3,1322,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,1322,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,1323,0)
 ;;=Z85.819^^3^39^112
 ;;^UTILITY(U,$J,358.3,1323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1323,1,3,0)
 ;;=3^Prsnl hx of malig neoplm of unsp site lip,oral cav,& pharynx
 ;;^UTILITY(U,$J,358.3,1323,1,4,0)
 ;;=4^Z85.819
 ;;^UTILITY(U,$J,358.3,1323,2)
 ;;=^5063440
 ;;^UTILITY(U,$J,358.3,1324,0)
 ;;=Z85.818^^3^39^108
 ;;^UTILITY(U,$J,358.3,1324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1324,1,3,0)
 ;;=3^Prsnl hx of malig neoplm of site of lip, oral cav, & pharynx
 ;;^UTILITY(U,$J,358.3,1324,1,4,0)
 ;;=4^Z85.818
 ;;^UTILITY(U,$J,358.3,1324,2)
 ;;=^5063439
 ;;^UTILITY(U,$J,358.3,1325,0)
 ;;=Z85.01^^3^39^100
 ;;^UTILITY(U,$J,358.3,1325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1325,1,3,0)
 ;;=3^Prsnl hx of malig neoplm of esophagus
 ;;^UTILITY(U,$J,358.3,1325,1,4,0)
 ;;=4^Z85.01
 ;;^UTILITY(U,$J,358.3,1325,2)
 ;;=^5063395
 ;;^UTILITY(U,$J,358.3,1326,0)
 ;;=Z85.028^^3^39^110
 ;;^UTILITY(U,$J,358.3,1326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1326,1,3,0)
 ;;=3^Prsnl hx of malig neoplm of stomach
 ;;^UTILITY(U,$J,358.3,1326,1,4,0)
 ;;=4^Z85.028
 ;;^UTILITY(U,$J,358.3,1326,2)
 ;;=^5063397
 ;;^UTILITY(U,$J,358.3,1327,0)
 ;;=Z85.038^^3^39^102
 ;;^UTILITY(U,$J,358.3,1327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1327,1,3,0)
 ;;=3^Prsnl hx of malig neoplm of large intestine
 ;;^UTILITY(U,$J,358.3,1327,1,4,0)
 ;;=4^Z85.038
 ;;^UTILITY(U,$J,358.3,1327,2)
 ;;=^5063399
 ;;^UTILITY(U,$J,358.3,1328,0)
 ;;=Z85.048^^3^39^107
 ;;^UTILITY(U,$J,358.3,1328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1328,1,3,0)
 ;;=3^Prsnl hx of malig neoplm of rectum, rectosig junct, and anus
 ;;^UTILITY(U,$J,358.3,1328,1,4,0)
 ;;=4^Z85.048
 ;;^UTILITY(U,$J,358.3,1328,2)
 ;;=^5063401
 ;;^UTILITY(U,$J,358.3,1329,0)
 ;;=Z85.118^^3^39^98
 ;;^UTILITY(U,$J,358.3,1329,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI03Y
